Literature DB >> 11017988

Commentary

.   

Abstract

Year:  2000        PMID： 11017988      PMCID： PMC1071129          DOI： 10.1136/ewjm.173.4.252-a

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  3 in total

1.  Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada.

Authors:  A Lussier; A A Cividino; C A McFarlane; W P Olszynski; W J Potashner; R De Médicis
Journal:  J Rheumatol       Date:  1996-09       Impact factor: 4.666

2.  The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.

Authors:  M E Adams; M H Atkinson; A J Lussier; J I Schulz; K A Siminovitch; J P Wade; M Zummer
Journal:  Osteoarthritis Cartilage       Date:  1995-12       Impact factor: 6.576

3.  Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.

Authors:  R D Altman; R Moskowitz
Journal:  J Rheumatol       Date:  1998-11       Impact factor: 4.666
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.